Quest Diagnostics Incorporated (DGX): Healthcare sector is gaining shares


Quest Diagnostics Incorporated (NYSE:DGX) changes shares on Thursday trading session, with a change of 3.59% or $3.75 shares. The trading starts at $104.39 and closed at $104.55 throughout the day. The trading session low price was $103.26 and day high was $108.63 on Thursday, June 25. After the session, the Healthcare sector daily volume shifted to 1.74 million while its average volume is 1.87M. In other hand, the DGX market cap reached to $14.86B.

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -2.51% and down -6.27% for month. Its quarterly performance was 21.73% above, while its half year performance is up 1.01%. DGX yearly performance stood at positive 8.60% and rise 1.41% for year-to-date. Current recommendation for Quest Diagnostics Incorporated is 2.30.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. DGX EPS (TTM) for 12-month is 5.66. EPS for this year is 18.70%, while for the next year its value is 7.42. Sales growth for the current quarter is 3.65 while its EPS Q/Q reached -38.80%. It has an EPS of 10.20% up for past five years and for the next five years will be up 5.24%.

Vanguard Group, Inc. (The), Blackrock Inc. and State Street Corporation are the top three holders in Quest Diagnostics Incorporated (DGX) stock. On Mar 30, 2020, Vanguard Group, Inc. (The) has 15.76 million shares which valued 1.27 billion. On Mar 30, 2020, Blackrock Inc. owned 12.86 million shares which valued at 1.03 billion. On Mar 30, 2020, State Street Corporation has a total of 6.82 million shares which valued at 547.55 million. In the end, State Street Corporation have 5.10% shares outstanding of Quest Diagnostics Incorporated (DGX) on Mar 30, 2020. The insider ownership moved to 0.50% and institutional holding shifted to 93.70%.

The company posted an EPS (TTM) of 5.66. According to the most recent quarter report on (Jun 2020), 13 analysts estimated an average EPS of 0.08, while 1.73 EPS posted a year ago period. Analyst Estimated EPS for DGX published in the report was -0.66-0.5 during the same period. Comparing with last year, the average estimated EPS was 1.73 which is higher than 0.94 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for DGX rise 3.54% for period of 200 days. SMA for 50 days was -1.43% which is showing red signal, while SMA-20 was -5.17%. The moving average value for Quest Diagnostics Incorporated (DGX) is 104.81 and 112.74 for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in DGX stock. On Jun 08, RING TIMOTHY M, Director, sold 11,730 trading shares at the cost of $116.60, which valued at 1.37 million. On Jun 08, GUINAN MARK, Executive Vice President & CFO, sold 72,596 shares at the cost of $117.23, with total shares of 73,579. On Apr 27, EGLINTON MANNER CARRIE, SVP, Advanced Diagnostics, sold 5,000 shares at the cost of 111.02. After this transaction, EGLINTON MANNER CARRIE total shares reached to 22,390 which valued at 0.56 million.